Ellison Dial Suthoff

Ellison Dial Suthoff is an experienced professional in health economics and outcomes research, currently serving as Executive Director at Sage Therapeutics since February 2018, following progressive leadership roles in the company. Prior experience includes director-level positions at Vertex Pharmaceuticals and managerial roles at Analysis Group, where statistical analysis and market opportunity research were conducted. Ellison also gained valuable experience as a summer intern at Novartis in sales forecasting. Educational credentials include an MBA in General Management from Harvard Business School and a BS in Mathematics from Haverford College.